100 related articles for article (PubMed ID: 6097178)
1. Investigation of antiviral activity of 1-beta-D-arabinofuranosylthymine (ara-T) and 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-ara-U) in monkeys infected with simian varicella virus.
Soike KF; Baskin G; Cantrell C; Gerone P
Antiviral Res; 1984 Oct; 4(5):245-57. PubMed ID: 6097178
[TBL] [Abstract][Full Text] [Related]
2. Oral bioavailability and anti-simian varicella virus efficacy of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) in monkeys.
Soike K; Huang JL; Tu JI; Stouffer B; Mitroka JG; Swerdel M; Olsen S; Bonner DP; Tuomari AV; Field AK
J Infect Dis; 1992 Apr; 165(4):732-6. PubMed ID: 1313071
[TBL] [Abstract][Full Text] [Related]
3. Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracils.
Machida H; Sakata S; Kuninaka A; Yoshino H
Antimicrob Agents Chemother; 1981 Jul; 20(1):47-52. PubMed ID: 6269482
[TBL] [Abstract][Full Text] [Related]
4. Activity of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil against simian varicella virus infections in African green monkeys.
Soike KF; Cantrell C; Gerone PJ
Antimicrob Agents Chemother; 1986 Jan; 29(1):20-5. PubMed ID: 3729332
[TBL] [Abstract][Full Text] [Related]
5. Strains of varicella-zoster virus resistant to 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
Sakuma T
Antimicrob Agents Chemother; 1984 Jun; 25(6):742-6. PubMed ID: 6331298
[TBL] [Abstract][Full Text] [Related]
6. 6-Dimethylamino-9-(beta-D-arabinofuranosyl)-9H-purine: pharmacokinetics and antiviral activity in simian varicella virus-infected monkeys.
Soike KF; Huang JL; Lambe CU; Nelson DJ; Ellis MN; Krenitsky TA; Koszalka GW
Antiviral Res; 1993 Jan; 20(1):13-20. PubMed ID: 8457145
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compounds.
Machida H; Sakata S
Antiviral Res; 1984 Jun; 4(3):135-41. PubMed ID: 6089657
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of simian varicella virus infection of monkeys by 1-(2-deoxy-2- fluoro-1-beta-D-arabinofuranosyl)-5-ethyluracil (FEAU) and synergistic effects of combination with human recombinant interferon-beta.
Soike KF; Chou TC; Fox JJ; Watanabe KA; Gloff CA
Antiviral Res; 1990 Apr; 13(4):165-74. PubMed ID: 2166466
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against thymidine kinase negative strains of varicella-zoster virus.
Kawai H; Yoshida I; Suzutani T
Microbiol Immunol; 1993; 37(11):877-82. PubMed ID: 8295566
[TBL] [Abstract][Full Text] [Related]
10. A proposed mechanism for the selective inhibition of human cytomegalovirus replication by 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-fluorouracil.
Suzuki S; Misra HK; Wiebe LI; Knaus EE; Tyrrell DL
Mol Pharmacol; 1987 Mar; 31(3):301-6. PubMed ID: 3031445
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the in vitro and in vivo anti-herpes activities of 1-beta-D-arabinofuranosylthymine and its 5'-monophosphate.
Machida H; Sakata S; Morozumi M; Kiyanagi T; Kuninaka A; Yoshino H
Antiviral Res; 1982 Sep; 2(4):217-26. PubMed ID: 6293376
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of various 1-beta-D-arabinofuranosyl-E-5-halogenovinyluracils and E-5-bromovinyl-2'-deoxyuridine against salmon herpes virus, Oncorhynchus masou virus (OMV).
Suzuki S; Machida H; Saneyoshi M
Antiviral Res; 1987 Feb; 7(2):79-86. PubMed ID: 3034148
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H
Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386
[TBL] [Abstract][Full Text] [Related]
14. Effect of treatment with 1-beta-D-arabinofuranosylthymine of experimental encephalitis induced by herpes simplex virus in mice.
Machida H; Ichikawa M; Kuninaka A; Saneyoshi M; Yoshino H
Antimicrob Agents Chemother; 1980 Feb; 17(2):109-14. PubMed ID: 7387135
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and antiviral activity of a novel isonucleoside, BMS-181165, against simian varicella virus infection in African green monkeys.
Soike KF; Huang JL; Russell JW; Whiterock VJ; Sundeen JE; Stratton LW; Clark JM
Antiviral Res; 1994 Apr; 23(3-4):219-24. PubMed ID: 8042861
[TBL] [Abstract][Full Text] [Related]
16. Sorivudine (BV-ara-U) for the treatment of complicated refractory varicella zoster virus infection in HIV-infected patients.
Burdge DR; Voigt R; Lindley JI; Gage L; Sacks SL
AIDS; 1995 Jul; 9(7):810-2. PubMed ID: 7546429
[No Abstract] [Full Text] [Related]
17. Effects of various nucleosides on antiviral activity and metabolism of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus types 1 and 2.
Suzutani T; Machida H; Sakuma T; Azuma M
Antimicrob Agents Chemother; 1988 Oct; 32(10):1547-51. PubMed ID: 2847634
[TBL] [Abstract][Full Text] [Related]
18. Antiherpes activity of [E]-5-(1-propenyl)-2'-deoxyuridine and 5-(1-propenyl)-1-beta-D-arabinofuranosyluracil.
Stening G; Gotthammar B; Larsson A; Alenius S; Johansson NG; Oberg B
Antiviral Res; 1981 Nov; 1(4):213-23. PubMed ID: 6280606
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of selective inhibition of human cytomegalovirus replication by 1-beta-D-arabinofuranosyl-5-fluorouracil.
Suzuki S; Saneyoshi M; Nakayama C; Nishiyama Y; Yoshida S
Antimicrob Agents Chemother; 1985 Aug; 28(2):326-30. PubMed ID: 3010844
[TBL] [Abstract][Full Text] [Related]
20. Ineffectiveness of adenine arabinoside and adenine arabinoside 5'-monophosphate in simian varicella infection.
Soike KF; Felsenfeld AD; Gibson S; Gerone PJ
Antimicrob Agents Chemother; 1980 Jul; 18(1):142-7. PubMed ID: 6158291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
